> top > projects > sentences > docs > PubMed:22008608 > annotations

PubMed:22008608 JSONTXT 40 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-118 Sentence denotes CysTRAQ - A combination of iTRAQ and enrichment of cysteinyl peptides for uncovering and quantifying hidden proteomes.
T1 0-118 Sentence denotes CysTRAQ - A combination of iTRAQ and enrichment of cysteinyl peptides for uncovering and quantifying hidden proteomes.
TextSentencer_T2 119-273 Sentence denotes Shotgun proteomics is capable of characterizing differences in both protein quality and quantity, and has been applied in various biomedical applications.
T2 119-273 Sentence denotes Shotgun proteomics is capable of characterizing differences in both protein quality and quantity, and has been applied in various biomedical applications.
TextSentencer_T3 274-437 Sentence denotes Unfortunately, the high complexity and dynamic range of proteins in studied samples, clinical in particular, often hinders the identification of relevant proteins.
T3 274-437 Sentence denotes Unfortunately, the high complexity and dynamic range of proteins in studied samples, clinical in particular, often hinders the identification of relevant proteins.
TextSentencer_T4 438-628 Sentence denotes Indeed, information-rich, low abundance proteins often remain undetected, whereas repeatedly reported altered concentrations in high abundance proteins are often ambiguous and insignificant.
T4 438-628 Sentence denotes Indeed, information-rich, low abundance proteins often remain undetected, whereas repeatedly reported altered concentrations in high abundance proteins are often ambiguous and insignificant.
TextSentencer_T5 629-751 Sentence denotes Several techniques have therefore been developed to overcome this obstacle and provide a deeper insight into the proteome.
T5 629-751 Sentence denotes Several techniques have therefore been developed to overcome this obstacle and provide a deeper insight into the proteome.
TextSentencer_T6 752-906 Sentence denotes Here we report a novel approach, which enables iTRAQ reagent quantitation of peptides fractionated based on presence of a cysteine residue (thus CysTRAQ).
T6 752-906 Sentence denotes Here we report a novel approach, which enables iTRAQ reagent quantitation of peptides fractionated based on presence of a cysteine residue (thus CysTRAQ).
TextSentencer_T7 907-1065 Sentence denotes For the first time, we prove that iTRAQ quantitation is fully compatible with cysteinyl peptide enrichment and is not influenced by the fractionation process.
T7 907-1065 Sentence denotes For the first time, we prove that iTRAQ quantitation is fully compatible with cysteinyl peptide enrichment and is not influenced by the fractionation process.
TextSentencer_T8 1066-1373 Sentence denotes Moreover, the employment of the method combined with high-resolution TripleTOF 5600 mass spectrometer for very fast MS/MS acquisition in human amniotic fluid analysis significantly increased the number of identified proteins, which were simultaneously quantified owing to the introduction of iTRAQ labeling.
T8 1066-1373 Sentence denotes Moreover, the employment of the method combined with high-resolution TripleTOF 5600 mass spectrometer for very fast MS/MS acquisition in human amniotic fluid analysis significantly increased the number of identified proteins, which were simultaneously quantified owing to the introduction of iTRAQ labeling.
TextSentencer_T9 1374-1560 Sentence denotes We herein show that CysTRAQ is a robust and straightforward method with potential application in quantitative proteomics experiments, i.e. as an alternative to the ICAT reagent approach.
T9 1374-1560 Sentence denotes We herein show that CysTRAQ is a robust and straightforward method with potential application in quantitative proteomics experiments, i.e. as an alternative to the ICAT reagent approach.